Institution
Beijing Obstetrics and Gynecology Hospital
- 8running trials
- 5closed trials
- 3,659publications (OpenAlex)
Running trials
Recruiting
Recruiting
Recruiting
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
Not yet recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer2 recruiting
- Endometrial cancer2 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Polycystic ovary syndrome1 recruiting
Closed trials
Registry name variants (4)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Beijing, Beijing Municipality 100026
9 trials
Beijing Obstetrics and Gynecology Hospital
Beijing, 100026
2 trials
NCT06742710Liraglutide Treatment in Obese Infertile PCOS Women
Contact: Prof. Yang
NCT06584032Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
Contact: Yumei Wu
Beijing Obstetrics and Gynecology Hospital,Capital Med.Uni.
Beijing, 100026
1 trial
Beijing Obstetrics & Gynecology Hospital, Capital Medical University
Beijing
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Ovarian cancer36 works · 5 trials
- Cervical cancer22 works · 3 trials
- Gestational diabetes21 works · 1 trial
- Polycystic ovary syndrome14 works · 1 trial
- Endometrial cancer13 works · 4 trials
- Female infertility4 works · 0 trials
Institution data: ROR 05787my06 (CC0-1.0)Updated 15 Nov 2026